Merck Files ProQuad MMR/Varicella Combo Pediatric Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
Company expects action on the BLA for a combination of its M-M-R II and Varivax vaccines by "early July" 2005. Three additional Merck vaccines are slated for submission over the next year, including agents for HPV and shingles.
You may also be interested in...
ProQuad Vaccine BLA Review Extended To September
FDA has extended its review of Merck's measles, mumps, rubella and varicella vaccine ProQuad by three months until Sept. 30
ProQuad Vaccine BLA Review Extended To September
FDA has extended its review of Merck's measles, mumps, rubella and varicella vaccine ProQuad by three months until Sept. 30
Varicella Vaccine Routine Two-Dose Regimen Not Recommended By CDC Advisory Committee
The Centers for Disease Control & Prevention Advisory Committee on Immunization Practices declined to recommend routine second-dose varicella vaccination June 30